Shopping Cart
- Remove All
Your shopping cart is currently empty
JMS-17-2 is a potent and selective antagonist of CX3CR1 (IC50: 0.32 nM).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $32 | In Stock | |
| 5 mg | $75 | In Stock | |
| 10 mg | $126 | In Stock | |
| 25 mg | $221 | In Stock | |
| 50 mg | $345 | In Stock | |
| 100 mg | $511 | In Stock | |
| 200 mg | $738 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $84 | In Stock |
| Description | JMS-17-2 is a potent and selective antagonist of CX3CR1 (IC50: 0.32 nM). |
| Targets&IC50 | CX3CR1:0.32 nM |
| Animal Research | SKBR3 human breast cancer cells were serum starved for four hours before being exposed to 50nM recombinant human FKN for 5 minutes, with or without previous incubation with either a CX3CR1 neutralizing antibody used at 15μg/ml or the JMS-17-2 antagonist (10nM) for 30 minutes at 37 ℃. |
| Molecular Weight | 419.95 |
| Formula | C25H26ClN3O |
| Cas No. | 1380392-05-1 |
| Smiles | Clc1ccc(cc1)C1CCN(CCCn2c3ccccc3n3cccc3c2=O)CC1 |
| Relative Density. | 1.26 g/cm3 (Predicted) |
| Color | White |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 11 mg/mL (26.19 mM), Sonication is recommended. | |||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.76 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.